GeneDx Holdings Corp. Finance Lease, Right-of-Use Asset, Amortization
GeneDx Holdings Corp. (WGS) reported Finance Lease, Right-of-Use Asset, Amortization of $398.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-02-23
- GeneDx Holdings Corp. finance lease, right-of-use asset, amortization for the quarter ending 2023-06-30 was $673.00K, a 26.21% decline year-over-year.
- GeneDx Holdings Corp. finance lease, right-of-use asset, amortization for the quarter ending 2023-03-31 was $775.00K, a 15.02% decline year-over-year.
- GeneDx Holdings Corp. finance lease, right-of-use asset, amortization for the quarter ending 2022-12-31 was $2.78M.
- GeneDx Holdings Corp. finance lease, right-of-use asset, amortization for the quarter ending 2022-09-30 was $912.00K.
- GeneDx Holdings Corp. finance lease, right-of-use asset, amortization for fiscal 2025 was $398.00K, a 38.49% decline from fiscal 2024.
- GeneDx Holdings Corp. finance lease, right-of-use asset, amortization for fiscal 2024 was $647.00K, a 67.16% decline from fiscal 2023.
- GeneDx Holdings Corp. finance lease, right-of-use asset, amortization for fiscal 2023 was $1.97M, a 64.30% decline from fiscal 2022.
- GeneDx Holdings Corp. finance lease, right-of-use asset, amortization for fiscal 2022 was $5.52M.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2025-12-31 | $398.00K 10-K · filed 2026-02-23 | |||
| 2024-12-31 | $647.00K 10-K · filed 2026-02-23 | |||
| 2023-12-31 | $1.97M 10-K · filed 2026-02-23 | |||
| 2023-06-30 | $673.00K 10-Q · filed 2023-08-08 | $1.45M 10-Q · filed 2023-08-08 | $4.23M derived: sum of 3 quarters · filed 2024-02-23 | $5.14M derived: sum of 4 quarters · filed 2024-02-23 |
| 2023-03-31 | $775.00K 10-Q · filed 2023-05-09 | $3.56M derived: sum of 2 quarters · filed 2024-02-23 | $4.47M derived: sum of 3 quarters · filed 2024-02-23 | $5.38M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-12-31 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $3.69M derived: sum of 2 quarters · filed 2024-02-23 | $4.61M derived: sum of 3 quarters · filed 2024-02-23 | $5.52M 10-K · filed 2024-02-23 |
| 2022-09-30 | $912.00K 10-Q · filed 2022-11-14 | $1.82M derived: sum of 2 quarters · filed 2023-08-08 | $2.74M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $912.00K 10-Q · filed 2023-08-08 | $1.82M 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $912.00K 10-Q · filed 2023-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |